首页>
外国专利>
Novel uses of combined selective dopamine D2 receptor antagonists and 5-HTsub1A/sub receptor agonists
Novel uses of combined selective dopamine D2 receptor antagonists and 5-HTsub1A/sub receptor agonists
展开▼
机译:选择性多巴胺D2受体拮抗剂和5-HT 1A sub>受体激动剂联合的新用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
Use of compounds being combined selective dopamine D2 receptor antagonists and 5-HT1A receptor agonists, in particular (R)-(-)-2-[5-4 fluorophenyl)-3-pyridylmethyl-aminomethyl]-chromane or a physiologically acceptable salt thereof or N-(4'-fluoro-3-biphenylmethyl)-N-2-(3-cycanophenoxy-ethyl)-amine or a physiologically acceptable salt thereof, for the manufacture of a medicament for use in veterinary medicine for the treatment of self directed traumatic disorders associated with behavioral stressors, compulsive disorders associated with behavioral stressors and/or anxiety disorders associated with behavioral stressors.
展开▼